Page last updated: 2024-11-07

methylenolactocin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

methylenolactocin: from Penicillium sp.; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID133968
MeSH IDM0159213

Synonyms (12)

Synonym
3-carboxy-2-methylene-4-nonanolide
3-furancarboxylic acid, tetrahydro-4-methylene-5-oxo-2-pentyl-, trans-(-)-
unii-6a2exc8cnc
6a2exc8cnc ,
112923-53-2
methylenolactocin
(2s,3r)-4-methylidene-5-oxo-2-pentyloxolane-3-carboxylic acid
DTXSID40920955
(2s,3r)-tetrahydro-4-methylene-5-oxo-2-pentyl-3-furancarboxylic acid
3-furancarboxylic acid, tetrahydro-4-methylene-5-oxo-2-pentyl-, (2s-trans)-
(-)-methylenolactomycin
methylenolactomycin

Research Excerpts

Effects

ExcerptReferenceRelevance
"Methylenolactocin has the molecular formula of C11H16O4 and possess an exomethylene lactone structure."( Methylenolactocin, a novel antitumor antibiotic from Penicillium sp.
Hirota, A; Nakagawa, M; Nakayama, M; Park, BK, 1988
)
2.44
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.53 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]